Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.42 USD | +0.59% | +1.07% | +1.44% |
Apr. 23 | Transcript : HealthStream, Inc., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 22 | Earnings Flash (HSTM) HEALTHSTREAM Posts Q1 Revenue $72.8M, vs. Street Est of $71.9M | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the past twelve months, EPS forecast has been revised upwards.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 49.87 times its estimated earnings per share for the ongoing year.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.44% | 829M | C+ | ||
+15.15% | 332B | B- | ||
+26.25% | 219B | B+ | ||
+6.72% | 148B | B | ||
+11.38% | 56.57B | D+ | ||
+19.91% | 33.46B | C+ | ||
+6.00% | 30.05B | B+ | ||
+126.40% | 23.02B | D+ | ||
+29.32% | 21.36B | B- | ||
+51.53% | 15.08B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HSTM Stock
- Ratings HealthStream, Inc.